Purple Biotech (PPBT) Other Non Operating Income (2014 - 2026)

Purple Biotech (PPBT) has reported Other Non Operating Income for 10 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non Operating Income fell 2156.76% year-over-year to -$1.7 million in Q2 2026; TTM through Jun 2026 was -$3.8 million, a 49.43% decrease from a year earlier, with the FY2025 full-year figure at -$1.5 million, up 54.38% from the prior year.
• Other Non Operating Income was -$1.7 million for Q2 2026 at Purple Biotech, up from -$2.2 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $61000.0 in Q4 2025 and troughed at -$3.5 million in Q4 2023.
• A 5-year average of -$831533.3 and a median of -$685000.0 in 2024 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income jumped 180.26% in 2025 and plunged 2156.76% in 2026, its largest moves.
• Over 5 years, Other Non Operating Income stood at -$21000.0 in 2022, then plunged by 16552.38% to -$3.5 million in 2023, then jumped by 97.83% to -$76000.0 in 2024, then jumped by 180.26% to $61000.0 in 2025, then sank by 2837.7% to -$1.7 million in 2026.
• The last three Other Non Operating Income figures came in at -$1.7 million (Q2 2026), -$2.2 million (Q1 2026), and $61000.0 (Q4 2025), per Business Quant data.